Ustekinumab-Ttwe 68225-0253
Product NDC
68225-0253- Manufacturer
- Patheon Italia S.p.a
- Dosage Form
- Injection, Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- February 22, 2025
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ustekinumab | 130 mg/26mL |
Packaging Options(1)
61 VIAL in 1 BOX (68225-253-00) / 30 mL in 1 VIAL